Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL.
Riva G, Luppi M, Lagreca I, Barozzi P, Quadrelli C, Vallerini D, Zanetti E, Basso S, Forghieri F, Morselli M, Maccaferri M, Paolini A, Fantuzzi V, Messerotti A, Maffei R, Iacobucci I, Martinelli G, Marasca R, Narni F, Comoli P, Potenza L.
Riva G, et al. Among authors: marasca r.
Br J Haematol. 2014 Jan;164(2):299-302. doi: 10.1111/bjh.12612. Epub 2013 Oct 18.
Br J Haematol. 2014.
PMID: 24134676
Free article.
No abstract available.